Cerebral Therapeutics Competitors and Similar CompaniesClear all
ZAI Lab's competitors and similar companies include Veloxis Pharmaceuticals.
 ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases. |  Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. | |
Founding Date | Founding Date 2014 | Founding Date 2002 |
Type | Type Public | Type Subsidiary |
Tags | ||
Locations | Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US | Locations København, DK HQ Cary, US Cary, US |
Employees | Employees 1,869 | Employees 54 |
Financial | ||
Revenue (est.) | Revenue (est.) $460.2m (FY, 2025) | Revenue (est.) kr39.5m (FY, 2018) |
Cost of goods | Cost of goods $190.5m (FY, 2025) | Cost of goods kr7.9m (FY, 2018) |
Gross profit | Gross profit $269.6m (FY, 2025) | Gross profit kr31.6m (FY, 2018) |
Net income | Net income ($175.5m) (FY, 2025) | Net income (kr5.3m) (FY, 2018) |
Funding | ||
Total funding raised | Total funding raised $ 985m | Total funding raised $ 60m |
For sources of this data, please see the company profile
View Company Profiles
Veloxis Pharmaceuticals
HQ
København, DK
Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View company